{"id":10778,"date":"2019-11-14T17:33:25","date_gmt":"2019-11-14T16:33:25","guid":{"rendered":"https:\/\/udic.es\/?p=10778"},"modified":"2019-11-29T09:39:31","modified_gmt":"2019-11-29T08:39:31","slug":"bomba-de-levodopa-subcutanea-en-parkinson-avancat","status":"publish","type":"post","link":"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/","title":{"rendered":"Bomba de levodopa subcut\u00e0nea en Parkinson avan\u00e7at"},"content":{"rendered":"

La UDIC iniciar\u00e0 un nou assaig cl\u00ednic que avalua l’administraci\u00f3 subcut\u00e0nia de levodopa, mitjan\u00e7ant una bomba de perfusi\u00f3 continua, per tractar les fluctuacions motores en Parkinson avan\u00e7at. Fins ara aix\u00f2 no havia estat possible degut a l’elevat volum requerit. Aquesta levodopa “ultra concentrada” que permet la seva administraci\u00f3 subcut\u00e0nia, per a un adequat control dels bloquejos motors que tant patiment provoquen als pacients. Es pret\u00e9n millorar la seva qualitat de vida. Al gener 2020 es realitzar\u00e0 la reuni\u00f3 d’investigadors a Barcelona.<\/p>\n","protected":false},"excerpt":{"rendered":"

La UDIC iniciar\u00e0 un nou assaig cl\u00ednic que avalua l’administraci\u00f3 subcut\u00e0nia de levodopa, mitjan\u00e7ant una bomba de perfusi\u00f3 continua, per tractar les fluctuacions motores en Parkinson avan\u00e7at. Fins ara aix\u00f2 no havia estat possible degut a l’elevat volum requerit. Aquesta levodopa “ultra concentrada” que permet la seva administraci\u00f3 subcut\u00e0nia, per a un adequat control dels…<\/p>\n","protected":false},"author":4,"featured_media":9272,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[125],"tags":[],"class_list":["post-10778","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-parkinson-ca"],"yoast_head":"\nBomba de levodopa subcut\u00e0nea en Parkinson avan\u00e7at - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica<\/title>\n<meta name=\"description\" content=\"La UDIC iniciar\u00e0 un nou assaig cl\u00ednic que avalua l'administraci\u00f3 subcut\u00e0nia de levodopa, mitjan\u00e7ant una bomba de perfusi\u00f3 continua, per tractar les\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bomba de levodopa subcut\u00e0nea en Parkinson avan\u00e7at - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\" \/>\n<meta property=\"og:description\" content=\"La UDIC iniciar\u00e0 un nou assaig cl\u00ednic que avalua l'administraci\u00f3 subcut\u00e0nia de levodopa, mitjan\u00e7ant una bomba de perfusi\u00f3 continua, per tractar les\" \/>\n<meta property=\"og:url\" content=\"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/\" \/>\n<meta property=\"og:site_name\" content=\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci%c3%b3-Cl%c3%adnica-447149502490430\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-11-14T16:33:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-11-29T08:39:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/Udichome3.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"5056\" \/>\n\t<meta property=\"og:image:height\" content=\"1752\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"SUSANA ANDRADE\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"SUSANA ANDRADE\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/\"},\"author\":{\"name\":\"SUSANA ANDRADE\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/7b598050df55fbeadbf6cdc699c31c03\"},\"headline\":\"Bomba de levodopa subcut\u00e0nea en Parkinson avan\u00e7at\",\"datePublished\":\"2019-11-14T16:33:25+00:00\",\"dateModified\":\"2019-11-29T08:39:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/\"},\"wordCount\":95,\"publisher\":{\"@id\":\"https:\/\/udic.es\/#organization\"},\"image\":{\"@id\":\"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/Udichome3.jpg\",\"articleSection\":[\"Parkinson\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/\",\"url\":\"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/\",\"name\":\"Bomba de levodopa subcut\u00e0nea en Parkinson avan\u00e7at - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\",\"isPartOf\":{\"@id\":\"https:\/\/udic.es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/Udichome3.jpg\",\"datePublished\":\"2019-11-14T16:33:25+00:00\",\"dateModified\":\"2019-11-29T08:39:31+00:00\",\"description\":\"La UDIC iniciar\u00e0 un nou assaig cl\u00ednic que avalua l'administraci\u00f3 subcut\u00e0nia de levodopa, mitjan\u00e7ant una bomba de perfusi\u00f3 continua, per tractar les\",\"breadcrumb\":{\"@id\":\"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/#primaryimage\",\"url\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/Udichome3.jpg\",\"contentUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/Udichome3.jpg\",\"width\":5056,\"height\":1752,\"caption\":\"Udichome3\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/udic.es\/ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bomba de levodopa subcut\u00e0nea en Parkinson avan\u00e7at\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/udic.es\/#website\",\"url\":\"https:\/\/udic.es\/\",\"name\":\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\",\"description\":\"Unitat D'Investigaci\u00f3 Cl\u00ednica\",\"publisher\":{\"@id\":\"https:\/\/udic.es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/udic.es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/udic.es\/#organization\",\"name\":\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\",\"url\":\"https:\/\/udic.es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/udic.es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png\",\"contentUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png\",\"width\":408,\"height\":123,\"caption\":\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\"},\"image\":{\"@id\":\"https:\/\/udic.es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci\u00f3-Cl\u00ednica-447149502490430\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/7b598050df55fbeadbf6cdc699c31c03\",\"name\":\"SUSANA ANDRADE\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ae155cf03dc49fd596e9750d3cfd63ee?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ae155cf03dc49fd596e9750d3cfd63ee?s=96&d=mm&r=g\",\"caption\":\"SUSANA ANDRADE\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bomba de levodopa subcut\u00e0nea en Parkinson avan\u00e7at - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","description":"La UDIC iniciar\u00e0 un nou assaig cl\u00ednic que avalua l'administraci\u00f3 subcut\u00e0nia de levodopa, mitjan\u00e7ant una bomba de perfusi\u00f3 continua, per tractar les","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/","og_locale":"ca_ES","og_type":"article","og_title":"Bomba de levodopa subcut\u00e0nea en Parkinson avan\u00e7at - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","og_description":"La UDIC iniciar\u00e0 un nou assaig cl\u00ednic que avalua l'administraci\u00f3 subcut\u00e0nia de levodopa, mitjan\u00e7ant una bomba de perfusi\u00f3 continua, per tractar les","og_url":"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/","og_site_name":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","article_publisher":"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci%c3%b3-Cl%c3%adnica-447149502490430\/","article_published_time":"2019-11-14T16:33:25+00:00","article_modified_time":"2019-11-29T08:39:31+00:00","og_image":[{"width":5056,"height":1752,"url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/Udichome3.jpg","type":"image\/jpeg"}],"author":"SUSANA ANDRADE","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"SUSANA ANDRADE"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/#article","isPartOf":{"@id":"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/"},"author":{"name":"SUSANA ANDRADE","@id":"https:\/\/udic.es\/#\/schema\/person\/7b598050df55fbeadbf6cdc699c31c03"},"headline":"Bomba de levodopa subcut\u00e0nea en Parkinson avan\u00e7at","datePublished":"2019-11-14T16:33:25+00:00","dateModified":"2019-11-29T08:39:31+00:00","mainEntityOfPage":{"@id":"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/"},"wordCount":95,"publisher":{"@id":"https:\/\/udic.es\/#organization"},"image":{"@id":"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/#primaryimage"},"thumbnailUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/Udichome3.jpg","articleSection":["Parkinson"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/","url":"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/","name":"Bomba de levodopa subcut\u00e0nea en Parkinson avan\u00e7at - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","isPartOf":{"@id":"https:\/\/udic.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/#primaryimage"},"image":{"@id":"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/#primaryimage"},"thumbnailUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/Udichome3.jpg","datePublished":"2019-11-14T16:33:25+00:00","dateModified":"2019-11-29T08:39:31+00:00","description":"La UDIC iniciar\u00e0 un nou assaig cl\u00ednic que avalua l'administraci\u00f3 subcut\u00e0nia de levodopa, mitjan\u00e7ant una bomba de perfusi\u00f3 continua, per tractar les","breadcrumb":{"@id":"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/#primaryimage","url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/Udichome3.jpg","contentUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/Udichome3.jpg","width":5056,"height":1752,"caption":"Udichome3"},{"@type":"BreadcrumbList","@id":"https:\/\/udic.es\/ca\/bomba-de-levodopa-subcutanea-en-parkinson-avancat\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/udic.es\/ca\/"},{"@type":"ListItem","position":2,"name":"Bomba de levodopa subcut\u00e0nea en Parkinson avan\u00e7at"}]},{"@type":"WebSite","@id":"https:\/\/udic.es\/#website","url":"https:\/\/udic.es\/","name":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","description":"Unitat D'Investigaci\u00f3 Cl\u00ednica","publisher":{"@id":"https:\/\/udic.es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/udic.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/udic.es\/#organization","name":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","url":"https:\/\/udic.es\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/udic.es\/#\/schema\/logo\/image\/","url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png","contentUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png","width":408,"height":123,"caption":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica"},"image":{"@id":"https:\/\/udic.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci\u00f3-Cl\u00ednica-447149502490430\/"]},{"@type":"Person","@id":"https:\/\/udic.es\/#\/schema\/person\/7b598050df55fbeadbf6cdc699c31c03","name":"SUSANA ANDRADE","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/udic.es\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ae155cf03dc49fd596e9750d3cfd63ee?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ae155cf03dc49fd596e9750d3cfd63ee?s=96&d=mm&r=g","caption":"SUSANA ANDRADE"}}]}},"_links":{"self":[{"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/posts\/10778","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/comments?post=10778"}],"version-history":[{"count":3,"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/posts\/10778\/revisions"}],"predecessor-version":[{"id":10815,"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/posts\/10778\/revisions\/10815"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/media\/9272"}],"wp:attachment":[{"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/media?parent=10778"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/categories?post=10778"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/tags?post=10778"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}